Announcement PDF Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 1 / 5 Announcement Summary Entity name ONCOSIL MEDICAL LTD Announcement Type New announcement Date of this announcement Monday October 26, 2026 Details of +securities that have ceased ASX +security code Security description Number of +securities that have ceased The +securities have ceased due to Date of cessation OSLAM PERFORMANCE RIGHTS EXPIRING 25-OCT-2026 24,156 Expiry of option or other convertible security without exercise or conversion 25/10/2026 Refer to next page for full details of the announcement Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 2 / 5 Part 1 - Announcement Details 1.1 Name of +Entity ONCOSIL MEDICAL LTD We (the entity named above) provide the following information about our issued capital. 1.2 Registered Number Type ACN Registration Number 113824141 1.3 ASX issuer code OSL 1.4 The announcement is 1.5 Date of this announcement 26/10/2026 New announcement Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 3 / 5 Part 2 - Details of +equity securities or +debt securities that have ceased ASX +Security Code and Description OSLAM : PERFORMANCE RIGHTS EXPIRING 25-OCT-2026 Unquoted +equity securities that have ceased Number of securities that have ceased 24,156 Reason for cessation Expiry of option or other convertible security without exercise or conversion Date of cessation 25/10/2026 Is the entity paying any consideration for the cessation? Any other information the entity wishes to notify to ASX about the cessation? No Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 4 / 5 Part 3 - Issued capital following changes Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise: The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX) ASX +security code and description Total number of +securities on issue OSL : ORDINARY FULLY PAID 36,703,941 OSLOE : OPTION EXPIRING 30-JUN-2027 10,268,157 OSLOC : OPTION EXPIRING 20-DEC-2027 2,140,009 OSLOD : OPTION EXPIRING 31-JUL-2027 7,661,625 OSLO : OPTION EXPIRING 30-APR-2027 4,252,861 3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue OSLAB : PERFORMANCE RIGHTS 228,750 OSLAR : OPTION EXPIRING 29-NOV-2028 EX $12.00 102,500 OSLAT : OPTION EXPIRING 28-NOV-2028 EX $1.80 114,157 OSLAU : OPTION EXPIRING 28-NOV-2030 EX $1.80 172,811 OSLAS : OPTION EXPIRING 14-JAN-2030 EX $12.00 7,500 OSLAC : OPTION EXPIRING 30-JUN-2029 EX NIL 687,092 OSLAM : PERFORMANCE RIGHTS EXPIRING 25-OCT-2026 0 OSLAN : OPTION EXPIRING 25-OCT-2027 EX $48.00 10,457 Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form. Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 5 / 5